Lees Summit, MO, United States of America

Michael J Baltezor

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Carderm Capital L.p.. Active years: 1994-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Baltezor. Retrieved from https://idiyas.com/inventor/michael-j-baltezor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 226(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Michael J Baltezor

Introduction

Michael J Baltezor is an accomplished inventor based in Lees Summit, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly with his work on diltiazem formulations. With a total of three patents to his name, Baltezor's innovations reflect his dedication to improving medication delivery and patient care.

Latest Patents

Among his latest patents is a diltiazem formulation designed for once-a-day administration. This formulation features a blend of diltiazem beads that possess two differing dissolution profiles, allowing for more effective and convenient dosing. This innovative approach aims to enhance patient compliance and therapeutic outcomes.

Career Highlights

Baltezor is currently associated with Carderm Capital L.P., where he continues to develop and refine his pharmaceutical inventions. His work has garnered attention for its potential to improve treatment regimens for patients requiring diltiazem.

Collaborations

Some of his notable coworkers include Dennis L Hendrickson and Dan C Dimmitt. Their collaborative efforts contribute to the innovative environment at Carderm Capital L.P.

Conclusion

Michael J Baltezor's contributions to pharmaceutical innovations, particularly in diltiazem formulations, showcase his commitment to enhancing patient care through effective medication solutions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…